Ye Ziqi, Hong Yun, Wu Xiuhua, Hong Dongsheng, Zhang Yanfang, Dong Xihao, Rao Yuefeng, Lu Xiaoyang
Department of Pharmacy, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 May 25;49(2):245-248. doi: 10.3785/j.issn.1008-9292.2020.03.12.
To explore the feasibility of radical resection for cancer patients complicated with coronavirus disease 2019 (COVID-19).
The management and clinical outcome of a sigmoid cancer patient with COVID-19 were analyzed.
The inflammation indicators and fever of this patient were effectively controlled and the lung lesions remained stable after active anti-viral treatment, then the radical colorectomy was performed after the viral negative conversion for twice.
The case indicates that radical resection can be performed in SARS-CoV-2 patients with twice-negative SARS-CoV-2 nucleic acid testing results.
探讨2019冠状病毒病(COVID-19)合并癌症患者行根治性切除术的可行性。
分析1例COVID-19合并乙状结肠癌患者的治疗及临床结局。
该患者经积极抗病毒治疗后炎症指标及发热得到有效控制,肺部病变保持稳定,在两次病毒核酸检测转阴后行根治性结肠切除术。
该病例表明,严重急性呼吸综合征冠状病毒2(SARS-CoV-2)核酸检测结果两次阴性的患者可行根治性切除术。